Healthcare Analyst Trucchio holds a conference call with CEO Etkin to discuss Alto’s precision psychiatry pipeline on May 5 at 12 pm hosted by H.C. Wainwright.Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANRO:
- Alto Neuroscience initiates Phase 2b trial of ALTO-207 in TRD
- Alto Neuroscience files to sell 6M shares of common stock for holders
- Alto Neuroscience’s ALTO-101 miss doesn’t impact thesis, says H.C. Wainwright
- Alto Neuroscience price target lowered to $21 from $22 at Wedbush
- Morning Movers: Immunovant sinks after batoclimab trials miss goal